Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,786 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.
Nishikawa T, Inoue T, Otsuka T, Kuno I, Kukita Y, Nakamura H, Ikeda Y, Yasui T, Shioyama W, Oka T, Honma K, Hatakeyama K, Miyata H, Isei T, Ishihara R, Kumagai T, Nishimura K, Fujita M. Nishikawa T, et al. Among authors: otsuka t. PLoS One. 2022 Nov 15;17(11):e0275865. doi: 10.1371/journal.pone.0275865. eCollection 2022. PLoS One. 2022. PMID: 36378654 Free PMC article.
A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients.
Nishimura J, Hasegawa A, Kudo T, Otsuka T, Yasui M, Matsuda C, Haraguchi N, Ushigome H, Nakai N, Abe T, Hara H, Shinno N, Asukai K, Hasegawa S, Yamada D, Sugimura K, Yamamoto K, Wada H, Takahashi H, Omori T, Miyata H, Ohue M. Nishimura J, et al. Among authors: otsuka t. Sci Rep. 2021 Feb 25;11(1):4547. doi: 10.1038/s41598-021-84225-6. Sci Rep. 2021. PMID: 33633328 Free PMC article. Clinical Trial.
Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease.
Nishikawa T, Morishima T, Okawa S, Fujii Y, Otsuka T, Kudo T, Fujita T, Kamada R, Yasui T, Shioyama W, Oka T, Tabuchi T, Fujita M, Miyashiro I. Nishikawa T, et al. Among authors: otsuka t. BMC Cardiovasc Disord. 2021 Apr 13;21(1):177. doi: 10.1186/s12872-021-01968-w. BMC Cardiovasc Disord. 2021. PMID: 33849438 Free PMC article.
EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors.
Kunimasa K, Hirotsu Y, Kukita Y, Ueda Y, Sato Y, Kimura M, Otsuka T, Hamamoto Y, Tamiya M, Inoue T, Kawamura T, Nishino K, Amemiya K, Goto T, Mochizuki H, Honma K, Omata M, Kumagai T. Kunimasa K, et al. Among authors: otsuka t. Cancer Genet. 2021 Aug;256-257:131-135. doi: 10.1016/j.cancergen.2021.05.010. Epub 2021 May 28. Cancer Genet. 2021. PMID: 34130229
Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study.
Kadokawa Y, Inoue S, Tatsumi A, Uchida M, Fujita K, Takagi M, Inoue T, Ohe S, Nakai Y, Otsuka T, Abe Y, Nakabori T, Isei T, Kumagai T, Nishimura K, Ohkawa K. Kadokawa Y, et al. Among authors: otsuka t. JGH Open. 2023 Feb 13;7(2):87-97. doi: 10.1002/jgh3.12868. eCollection 2023 Feb. JGH Open. 2023. PMID: 36852148 Free PMC article.
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study.
Takenaka Y, Takemoto N, Otsuka T, Nishio M, Tanida M, Fujii T, Hayashi K, Suzuki M, Mori M, Yamamoto Y, Uno A, Inohara H. Takenaka Y, et al. Among authors: otsuka t. Oral Oncol. 2022 Sep;132:106018. doi: 10.1016/j.oraloncology.2022.106018. Epub 2022 Jul 11. Oral Oncol. 2022. PMID: 35835055
1,786 results